🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementThyroid nodules and GLP-1 — monitoring protocol for patients with history Page 2

Thyroid nodules and GLP-1 — monitoring protocol for patients with history

TinaHashiRN Thu, Feb 26, 2026 at 1:15 AM 8 replies 418 viewsPage 2 of 2
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Feb 26, 2026 at 4:05 AM#6

Saving this for reference. Quality thread.

Last edited: Feb 26, 2026 at 10:05 AM
47 9MikeFit_NJ, InsuranceTom, WendyG_ATL and 44 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Feb 26, 2026 at 4:22 AM#7

Slightly tangential to Thyroid nodules and GLP-1 but Dr.DermMIA reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

7 6Dr.GutHealth, amsterdam_pete, LondonLisa and 4 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Feb 26, 2026 at 4:39 AM#8

+1 to Dr.DermMIA. Especially the point about "A few questions about your Thyroid nodul..." — I have seen the same in my own experience with Thyroid nodules and GLP-1.

Last edited: Feb 26, 2026 at 10:39 AM
43 12kevin_tulsa, Dr.PainCLE, mike_mealprep and 40 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Feb 26, 2026 at 4:56 AM#9

Dr.PainCLE — that is really helpful context on Thyroid nodules and GLP-1. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

Last edited: Feb 26, 2026 at 10:56 AM
39 24Dr.PainCLE, mike_mealprep, NicoleRaleigh and 36 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Feb 26, 2026 at 5:13 AM#10

To answer PharmHunterJen's question specifically:

From a clinical standpoint, Thyroid nodules and GLP-1 is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

Last edited: Feb 26, 2026 at 10:13 AM
29 21Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 26 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register